DR5 antibodies and uses thereof

Details for Australian Patent Application No. 2006210779 (hide)

Owner Genentech, Inc.

Inventors Adams, Camellia W.

Agent Griffith Hack

Pub. Number AU-B-2006210779

PCT Pub. Number WO2006/083971

Priority 11/344,564 30.01.06 US; 60/649,550 02.02.05 US

Filing date 31 January 2006

Wipo publication date 10 August 2006

Acceptance publication date 22 September 2011

International Classifications

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

C12N 5/00 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines

C12N 15/00 (2006.01) Mutation or genetic engineering

Event Publications

16 August 2007 PCT application entered the National Phase

  PCT publication WO2006/083971 Priority application(s): WO2006/083971

22 September 2011 Application Accepted

  Published as AU-B-2006210779

19 January 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006210785-Method of controlling a pumping assembly

2006210778-Tumor necrosis factor inhibitors